University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO - Technical.ly Philly

Business

Oct. 28, 2019 11:36 am

University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO

The Penn spinout expects to make about $66 million in proceeds.
The stock market.

The stock market.

(Photo via Pexels https://www.pexels.com/photo/airport-bank-board-business-534216/)

Clinical-stage biotech company Cabaletta Bio Inc. announced that it had raised $74.8 million in an initial public offering Friday.

The University City-based company sold 6.8 million shares of common stock at $11 per share, according to a company statement. The pricing is below its target price of $14 to $16 per share listed in documents filed with the Securities and Exchange Commission, Philadelphia Business Journal reported.

Cabaletta, a University of Pennsylvania spinout, develops engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The announcement marks the city’s first life sciences IPO of 2019.

On Monday, Cabaletta (NASDAQ: CABA) was trading around $10 a share. The company said it expects its net proceeds from the offering to be about $66.2 million.

The technology was developed at Penn and resulted in the first commercially available CAR T cell products for the treatment of B cell cancers. The company was founded in 2017 by Dr. Michael Milone and Dr. Aimee Payne, who serve as co-chairs of Cabaletta’s Scientific Advisory Board, the company said. Dr. Steven Nichtberger also cofounded, and now serves as Cabaletta’s CEO.

The news follows two area bio and health company IPOs from 2018, PBJ reports: West Chester-based Verrica Pharmaceuticals’ $86.25 million IPO last June, and Phase Bio’s $46 million IPO last October.

This year, University City-based Spark Therapeutics (NASDAQ: ONCE) was the focus of what will be the largest exit ever within city limits for a venture-backed company, once it’s complete, after going public in 2015.

Advertisement

-30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

A cell and gene therapy development center is taking 680K square feet at KOP’s Discovery Labs

10 imagined futures: Philly’s tech community tells us what they envision for the next decade

Inside University City’s push to get those without four-year degrees into STEM careers

SPONSORED

Philly

How the history of Linode HQ inspires its employees

Malvern, PA

Vanguard

Developer – Entry-level

Apply Now

Malvern, PA

Vanguard

Data Governance Lead

Apply Now

Philadelphia

Inspire

Senior Software Engineer

Apply Now

Money Moves: These 5 Philly-area companies just raised millions in VC funding

Carisma Therapeutics raised nearly $60M in Series A funding. Now what?

A Center City biotech company is using an algorithm to help patients with memory loss

SPONSORED

Philly

When it comes to diversity, Vanguard puts its money where its mouth is

Philadelphia

Inspire

Software Engineer

Apply Now

1217 Sansom Street, Philadelphia, PA 19107

Perpay

Director of Merchandising

Apply Now

1217 Sansom Street, Philadelphia, PA

Perpay

Data Engineer

Apply Now

Sign-up for daily news updates from Technical.ly Philadelphia

Do NOT follow this link or you will be banned from the site!